ZP Therapeutics
The go-to commercialisation partner for the healthcare industry, and a valued partner in providing innovations to the healthcare community and expanding patient access. ZP Therapeutics is the partner of choice for companies looking for a sales and marketing partner in Asia.
See below for the Latest ZP Therapeutics News, Analysis, Profit Results, Share Price Information, and Commentary.
ZP Therapeutics bagged Healthcare Asia Pharma Awards 2024 for continuing medical education
                                                                                 
                    
                    It has engaged global medical experts and opinion makers to set up medical education events.
                
                                
            ZP Therapeutics bagged Healthcare Asia Pharma Awards 2024 for continuing medical education
                                                                                                                 
                            
                            It has engaged global medical experts and opinion makers to set up medical education events.
                        
                                                
                        
    
                    ZP Therapeutics earns dual accolades at the Healthcare Asia Pharma Awards
                                                                                                 
                        
                        The commercialisation division of Zuellig Pharma claims the Most Differentiated Service of the Year and Outcomes-based Contracting Model of the Year titles.
                    
                                        
                    
                 
            	         
                	         
                             
           
                                 
                                 
                                 
               
                                     
                                     
                                     
 
                                                                                                
                                                
                                                                                                                                         
 
                                                                                                
                                                
                                                                                                                                         
 
                                                                                                
                                                
                                                                                                                                         
 
                                                                                                
                                                
                                                                                                                                         
                 
                 
                 
                 
                 
                 
                